India's First Engineering Biology UG Course; Roadmap for Bioeconomy Leadership by 2035
UPSC / SSC current affairs note
Why in news
Union Minister Dr. Jitendra Singh announced India's first undergraduate course in Engineering Biology to prepare a future-ready biotechnology workforce. He also launched a roadmap to make India a global bioeconomy leader by 2035 through AI-driven biology and biomanufacturing.
Background
India's bioeconomy has grown from ~$10 billion in 2014 to ~$95 billion currently, with over 11,000 biotech startups. The government aims to build a sovereign biotechnology ecosystem leveraging talent, innovation, and industry partnerships.
Key facts
India's first undergraduate Engineering Biology course announced to create a skilled workforce at the intersection of engineering, biology, medicine, and emerging technologies.
Roadmap launched to make India a leading bioeconomy power by 2035, focusing on AI-based biology and biomanufacturing.
India's bioeconomy grew from ~$10 billion (2014) to ~$95 billion (2024), projected to reach ~$300 billion by 2030.
Over 11,000 biotech startups now exist in India, reflecting a transformed innovation ecosystem.
India developed the world's first DNA vaccine (ZyCoV-D) for COVID-19 and supplied vaccines to ~30 countries.
Indigenous advances in CAR-T cell therapy and gene-based therapies are making advanced treatments more affordable.
Future biotechnology will be driven by synthetic biology, AI-based biological research, and biomanufacturing.
IITs have started sending interdisciplinary program proposals in collaboration with medical institutions.
The roadmap includes industry perspectives and senior policymakers' addresses.
The course is described as foundational for the next phase of India's bioeconomy, akin to computer science driving the digital revolution.
Prelims pointers
- Engineering Biology undergraduate course: India's first
- Bioeconomy growth: $10 billion (2014) to $95 billion (2024), target $300 billion by 2030
- Biotech startups: over 11,000
- World's first DNA vaccine: ZyCoV-D (India)
- CAR-T cell therapy: indigenous advances
- Ministry: Science and Technology
- Minister: Dr. Jitendra Singh (Independent Charge, MoS for Science & Technology and Earth Sciences)
- Roadmap: '2035: India as a leading bioeconomy power'
- Key technologies: synthetic biology, AI-based biology, biomanufacturing
- IITs: interdisciplinary programs with medical institutions
Mains angles
- Discuss the role of Engineering Biology in transforming India's bioeconomy and achieving the $300 billion target by 2030.
- Critically examine the government's strategy to build a sovereign biotechnology ecosystem through education, innovation, and industry partnerships.
- Evaluate India's achievements in biotechnology (e.g., DNA vaccine, CAR-T therapy) and their impact on global healthcare and economic growth.
- How can AI-driven biology and biomanufacturing address challenges in healthcare, agriculture, and sustainability? Discuss with reference to India's roadmap.
- Analyze the importance of interdisciplinary education (engineering + biology) in preparing a future-ready workforce for emerging technologies.